Optimized Flow Cytometric Detection of Transient Receptor Potential Vanilloid-1 (TRPV1) in Human Hematological Malignancies
View ORCID ProfileSofia A Omari, View ORCID ProfileDominic P Geraghty, Alhossain A Khalafallah, Pooja Venkat, Yvette M Shegog, Scott J Ragg, View ORCID ProfileCharles E. de Bock, View ORCID ProfileMurray J Adams
doi: https://doi.org/10.1101/2021.08.04.21261521
Sofia A Omari
aSchool of Health Sciences, University of Tasmania. Locked Bag 1322, Launceston 7250, Tasmania, Australia
Dominic P Geraghty
aSchool of Health Sciences, University of Tasmania. Locked Bag 1322, Launceston 7250, Tasmania, Australia
Alhossain A Khalafallah
aSchool of Health Sciences, University of Tasmania. Locked Bag 1322, Launceston 7250, Tasmania, Australia
bLaunceston General Hospital, Charles Street, Launceston 7250, Tasmania, Australia
Pooja Venkat
cChildren’s Cancer Institute, School of Women’s and Children’s Health, Lowy Cancer Centre, University of New South Wales (UNSW), Sydney, NSW, Australia
Yvette M Shegog
aSchool of Health Sciences, University of Tasmania. Locked Bag 1322, Launceston 7250, Tasmania, Australia
Scott J Ragg
dPathology Department, Royal Hobart Hospital, 48 Liverpool Street, Hobart 7000, Tasmania, Australia
Charles E. de Bock
cChildren’s Cancer Institute, School of Women’s and Children’s Health, Lowy Cancer Centre, University of New South Wales (UNSW), Sydney, NSW, Australia
Murray J Adams
aSchool of Health Sciences, University of Tasmania. Locked Bag 1322, Launceston 7250, Tasmania, Australia
Data Availability
All data requests will be considered.
Posted August 08, 2021.
Optimized Flow Cytometric Detection of Transient Receptor Potential Vanilloid-1 (TRPV1) in Human Hematological Malignancies
Sofia A Omari, Dominic P Geraghty, Alhossain A Khalafallah, Pooja Venkat, Yvette M Shegog, Scott J Ragg, Charles E. de Bock, Murray J Adams
medRxiv 2021.08.04.21261521; doi: https://doi.org/10.1101/2021.08.04.21261521
Optimized Flow Cytometric Detection of Transient Receptor Potential Vanilloid-1 (TRPV1) in Human Hematological Malignancies
Sofia A Omari, Dominic P Geraghty, Alhossain A Khalafallah, Pooja Venkat, Yvette M Shegog, Scott J Ragg, Charles E. de Bock, Murray J Adams
medRxiv 2021.08.04.21261521; doi: https://doi.org/10.1101/2021.08.04.21261521
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2940)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12743)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4582)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4350)
- Nursing (236)
- Nutrition (639)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6935)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (488)
- Toxicology (60)
- Transplantation (212)
- Urology (180)